Advertisement

Latest News

FDA Approves Vadadustat (Vafseo) Tablets for Anemia Due to CKD in Adult Patients on Dialysis

10 hours ago

Vadadustat tablets are now approved for the treatment of anemia due to CKD in adults who have been receiving dialysis for ≥ 3 months.

Tildrakizumab Significantly Improves Skin Symptoms in Moderate-to-Severe Psoriasis

11 hours ago

At week 52, investigators noted an overall improvement of 93% in PASI scores from baseline.

Allogenic HSCT May Improve Sickle Cell Disease-Related Organ Dysfunction

13 hours ago

A new analysis summarized evidence on the effects of allogeneic HSCT on SCD-related organ dysfunction in pediatric and adult patients with SCD.

Novel CAR-T Cell Therapy Trial for Lupus Launched by Atlantic Health System

14 hours ago

Mohamed Cherry, MD, and Neil Kramer, MD, shed light on a phase 1 trial using CAR-T cell therapy for SLE and its potential implications for lupus treatment.

Vadadustat Response Influenced by Patient Background in Anemia from CKD

16 hours ago

A posthoc analysis of two phase 3 trials identified multiple independent factors associated with better response to vadadustat in patients with anemia.

Advertisement
Advertisement